| Patent | Date |
|---|
Quantification and preparation of pharmaceutical grade cantharidin
Grant 11,168,091 - Davidson , et al. November 9, 2 | 2021-11-09 |
Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives
App 20210070771 - Davidson; Matthew Gene ; et al. | 2021-03-11 |
Inhibitors Of Phospholipid Synthesis And Methods Of Use
App 20210002240 - Gouw; Arvin ; et al. | 2021-01-07 |
Synthesis Of Cantharidin
App 20200270269 - Davidson; Matthew Gene ; et al. | 2020-08-27 |
Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
Grant 10,745,413 - Davidson , et al. A | 2020-08-18 |
Quantification And Preparation Of Pharmaceutical Grade Cantharidin
App 20190031674 - Davidson; Matthew ; et al. | 2019-01-31 |
Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives
App 20190002474 - Davidson; Matthew ; et al. | 2019-01-03 |
Amorphous Ezatiostat Ansolvate
App 20140315812 - Schow; Steven R. | 2014-10-23 |
Tablet formulation of ezatiostat
Grant 8,361,971 - Lum , et al. January 29, 2 | 2013-01-29 |
Process for and intermediates in the preparation of canfosfamide and its salts
Grant 8,334,266 - Boulanger , et al. December 18, 2 | 2012-12-18 |
Process For And Intermediates In The Preparation Of Canfosfamide And Its Salts
App 20120238772 - Boulanger; William A. ; et al. | 2012-09-20 |
Process for and intermediates in the preparation of canfosfamide and its salts
Grant 8,198,247 - Boulanger , et al. June 12, 2 | 2012-06-12 |
Tablet Formulation Of Ezatiostat
App 20120021054 - Lum; Robert T. ; et al. | 2012-01-26 |
Sulfonylethyl phosphorodiamidates
Grant 8,093,231 - Allen , et al. January 10, 2 | 2012-01-10 |
Crystalline Ezatiostat Hydrochloride Ansolvate
App 20110301088 - Parent; Stephan D. ; et al. | 2011-12-08 |
Tablet Formulation Of Ezatiostat
App 20110300215 - Lum; Robert T. ; et al. | 2011-12-08 |
Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
App 20080159980 - Xu; Hua ; et al. | 2008-07-03 |
Sulfonylethyl Phosphorodiamidates
App 20080039429 - Allen; David R. ; et al. | 2008-02-14 |
Sulfonylethyl phosphorodiamidates
Grant 7,262,182 - Robinson , et al. August 28, 2 | 2007-08-28 |
Tripeptide and tetrapeptide sulfones
Grant 7,192,918 - Schow , et al. March 20, 2 | 2007-03-20 |
Tripeptide and tetrapeptide thioethers
Grant 7,129,215 - Aurrecoechea , et al. October 31, 2 | 2006-10-31 |
Tripeptide And Tetrapeptide Thioethers
App 20060160749 - Aurrecoechea; Natalia ; et al. | 2006-07-20 |
Tripeptide and tetrapeptide sulfones
App 20060148719 - Schow; Steven R. | 2006-07-06 |
Naphthalene ureas as glucose uptake enhancers
Grant 7,071,231 - Spevak , et al. July 4, 2 | 2006-07-04 |
Process for and intermediates in the preparation of canfosfamide and its salts
App 20060135409 - Boulanger; William A. ; et al. | 2006-06-22 |
Therapeutic compositions containing glutathione analogs
Grant 7,029,695 - Redelmeier , et al. April 18, 2 | 2006-04-18 |
Sulfonylethyl phosphorodiamidates
App 20050267075 - Allen, David R. ; et al. | 2005-12-01 |
Purine inhibitors of cyclin dependent kinase 2 and IkappaB-alpha
App 20050080261 - Lum, Robert T. ; et al. | 2005-04-14 |
Purine inhibitors of cyclin dependent kinase 2 & ikappabalpha
Grant 6,794,390 - Lum , et al. September 21, 2 | 2004-09-21 |
Purine inhibitors of cyclin dependent kinase 2 & IKBA
Grant 6,790,958 - Lum , et al. September 14, 2 | 2004-09-14 |
Alpha-ketoamide inhibitors of 20S proteasome
Grant 6,781,000 - Wang , et al. August 24, 2 | 2004-08-24 |
Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy
App 20040138140 - Xu, Hua ; et al. | 2004-07-15 |
Naphthylsulfonic acids and related compounds as glucose uptake agonists
Grant 6,653,321 - Spevak , et al. November 25, 2 | 2003-11-25 |
Benzene tricarboxylic acid derivatives as insulin receptor activators
Grant 6,600,069 - Robinson , et al. July 29, 2 | 2003-07-29 |
Novel naphthalene ureas as glucose uptake enhancers
App 20030135063 - Spevak, Wayne R. ; et al. | 2003-07-17 |
Therapeutic compositions containing glutathione analogs
App 20030100511 - Kauvar, Lawrence M. ; et al. | 2003-05-29 |
Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
Grant 6,506,739 - Herr , et al. January 14, 2 | 2003-01-14 |
Method for determining whether a compound is an insulin receptor kinase activator
App 20020151542 - Manchem, Prasad V.V.S.V. ; et al. | 2002-10-17 |
Benzene tricarboxylic acid derivatives as insulin receptor activators
App 20020103183 - Robinson, Louise ; et al. | 2002-08-01 |
Insulin receptor activators for the treatment of metabolic disorders induced by treatment with HIV protease inhibitors
App 20020061927 - Manchem, Prasad V.V.S.V. ; et al. | 2002-05-23 |
Purine inhibitors of cyclin dependent kinase 2 & IkBa
App 20020035252 - Lum, Robert T. ; et al. | 2002-03-21 |
Purine inhibitors of cyclin dependent kinase 2 & IkappaBalpha
App 20020032327 - Lum, Robert T. ; et al. | 2002-03-14 |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
Grant 6,337,338 - Kozlowski , et al. January 8, 2 | 2002-01-08 |
.alpha.-ketoamide inhibitors of 20S proteasome
Grant 6,075,150 - Wang , et al. June 13, 2 | 2000-06-13 |
Purine inhibitors of cyclin dependent kinase 2
Grant 5,866,702 - Mackman , et al. February 2, 1 | 1999-02-02 |
Inhibition of 26S and 20S proteasome by indanones
Grant 5,834,487 - Lum , et al. November 10, 1 | 1998-11-10 |
N.sup.6 mono heterocyclic substituted adenosine derivatives
Grant 5,789,416 - Lum , et al. August 4, 1 | 1998-08-04 |
Retroviral protease inhibitors
Grant 5,430,150 - Trova , et al. July 4, 1 | 1995-07-04 |
Urethanes and ureas that induce cytokine production
Grant 5,312,831 - Ayral-Kaloustian , et al. May 17, 1 | 1994-05-17 |
| 